Clinical trial
Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated…
NCT00454831 · DNP Canada, Industry · Completed
Key facts
| NCT number | NCT00454831 |
|---|---|
| Title | Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated Cholesterol |
| Official title | A 16 Week With 12 Week Active Treatment Multi-Center, Placebo-Controlled, Randomized Study Evaluating the Efficacy of HEP-40 Chitosan in Managing Moderate Hypercholesterolemia |
| Acronym | HEP-40 |
| Lead sponsor | DNP Canada, Industry |
| Collaborators | JSS Medical Research Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Device |
| Interventions | HEP-40 chitosan |
| Enrollment | 207 |
| Start date | Feb 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Apr 2, 2007 |
| Last update posted | Nov 16, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: